Pupillometry in Horner's Syndrome

NCT ID: NCT02978079

Last Updated: 2021-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-02-15

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Horner's syndrome (HS) is a result of interruption of the sympathetic innervation to the eye and ocular adnexa, which can occur due to carotid artery dissection (CAD), along which the sympathetic nerve fibers travel to reach the eye. Dissection of the carotid artery is one of the etiologies for ischemic stroke in young patients.

In our current study, we will explore the diagnostic accuracy of automated binocular pupillometry in the diagnosis or HS, and its potential in identifying dissection of the carotid artery in patients of young age who suffer ischemic stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Horner's Syndrome Stroke Dissection Carotid Artery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pupillometry in stroke patients

All eligible patients will undergo pupillometry test for the finding of Horner's syndrome

Group Type EXPERIMENTAL

Automated pupillometry

Intervention Type DEVICE

Automated pupillometry will be performed in patients with acute stroke with the intention of diagnosing Horner's syndrome

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Automated pupillometry

Automated pupillometry will be performed in patients with acute stroke with the intention of diagnosing Horner's syndrome

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults 60 years of age or younger
* Acute stroke (less than 72 hours from admission)
* Informed Consent as documented by signature (Appendix Informed Consent Form)
* Ability to understand the study information and consent form

Exclusion Criteria

* known history of HS
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
* Medications affecting pupillary response
* History of ocular surgery affecting the pupil
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Konrad Peter Weber

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Konrad P Weber, MD

Role: PRINCIPAL_INVESTIGATOR

Ophthalmology Department, University Hospital Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ophthalmology Department, University Hospital Zurich

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Konrad P Weber, MD

Role: primary

0041442555549

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KEK-Nr. 2016-02151

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.